Pemphigus in elderly adults: clinical presentation, treatment, and prognosis.
Saskia
S
Ingen-Housz-Oro
Marina
M
Alexandre
Christelle
C
Le Roux-Villet
Catherine
C
Picard-Dahan
Emmanuelle
E
Tancrède-Bohin
Nadège
N
Wallet-Faber
Emmanuel
E
Mahé
Edouard
E
Begon
Camille
C
Francès
Michèle
M
Sigal
Sabine
S
Grootenboer-Mignot
Françoise
F
Aucouturier
Chantal
C
André
Pierre
P
Wolkenstein
Olivier
O
Chosidow
Catherine
C
Prost-Squarcioni
D000368:Aged; D000369:Aged, 80 and over; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D003622:Dapsone / Q000627:therapeutic use; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D019084:Fluorescent Antibody Technique, Indirect; D005493:Folic Acid Antagonists / Q000627:therapeutic use; D006801:Humans; D006886:Hydroxychloroquine / Q000627:therapeutic use; D007155:Immunologic Factors / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D010392:Pemphigus / Q000175:diagnosis* / Q000188:drug therapy*; D011379:Prognosis; D012074:Remission Induction; D012189:Retrospective Studies; D000069283:Rituximab; D012720:Severity of Illness Index; D013256:Steroids / Q000627:therapeutic use; D016896:Treatment Outcome
D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D005493:Folic Acid Antagonists; D007155:Immunologic Factors; D007166:Immunosuppressive Agents; D013256:Steroids; D000069283:Rituximab; D006886:Hydroxychloroquine; D003622:Dapsone